Atlas Trials

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

Clinical trial NCT05450367 · COMPLETED

Trial details

NCT number
NCT05450367
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Study type
OBSERVATIONAL
Blood Cancer
Start date
2017-08-01
Primary completion
2022-07-15
Enrollment
249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.